Denver School of Science and Technology celebrates as 100% of graduates continue education
Denver School of Science and Technology celebrates graduating class as 100% head on to secondary edu
Denver School of Science and Technology celebrates graduating class as 100% head on to secondary edu
Denver School of Science and Technology celebrates graduating class as 100% head on to secondary edu
The graduating class of the Denver School of Science and Technology has a lot to brag about. They're getting ready to change the future as 100% of the class goes on to continue their education.
Even with FAFSA delays and a tough economy, DSST students earned over $24 million in scholarships.
CBS
Inside the Denver Coliseum Thursday, more than 700 students stepped up to the mic and announced their postgraduate plans. Nella García Urban, CEO of DSST, said it's a chance to celebrate their hard work. "They've been seeing themselves there for six years. There's a defining moment that happens for them when they're like, 'Wow, that could be me one day,' and I think that gives them the confidence to tell everyone where they're going."
CBS
For students like Fortunate Madueke, this is a dream come true. "I'm so excited I feel like I can cry. I am so proud of myself." The Nigerian-American senior is headed to Rice University on a full ride. She said her mother is very proud of her.
Fortunate Madueke
CBS
Fortunate credits her success partly to DSST.
Now, she aims to study neuroscience and become a dermatologist. After experiencing a misdiagnosis for a skin condition, she empathized with the need for more Black dermatologists. Fortunate said that Black women often don't get the dermatological care they need because of their skin tone.
"We are seen for our skin color, but then when we actually need things, we are often ignored," she explained.
CBS
An article by several dermatology specialists highlighted the racial disparities in dermatologic care. Dr. Shanthi Narla with St. Luke's University Health Network said diseases present differently on different skin tones, and nearly half of dermatologists don't feel their training is sufficient to diagnose skin diseases in patients with varying skin tones.
She also explained that some disorders disproportionately affect patients with certain skin tones, but their treatment is limited, and medical studies often don't include those patients.
The American Academy of Dermatology announced a three-year plan to address those disparities in 2021, aiming to improve education and treatment methods and create more comprehensive research. They also stressed the need for more medical professionals of diverse backgrounds who can understand the challenges their patients face.
Only one out of 10 STEM professionals identify as a person of color, said Urban. She said the school harnesses the power of diversity to put students on a different life trajectory, encouraging them to become leaders of the future. Leaders like Fortunate.
"There are only 3% Black dermatologists," said Fortunate. "And that's why I wanna go to Rice University, study neuroscience, and be on the pre-med track to become a dermatologist."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Los Angeles Times
an hour ago
- Los Angeles Times
Miller Children's & Women's Hospital Long Beach Transforms Maternal Care, Champions Equity and Dignity for All Mothers
Although in some areas, Diversity, Equity, and Inclusion (DEI) initiatives may be declining in healthcare, birth equity remains a priority for many hospitals in California, including Miller Children's & Women's Hospital in Long Beach. Raising awareness and developing strategies for birth equity is crucial to addressing racial and social disparities in maternal and infant health outcomes. In the United States, Black and Hispanic mothers are significantly more likely to experience complications during childbirth and have higher mortality rates as compared to other groups. At Miller Children's & Women's Hospital in Long Beach, over 5,500 babies are born each year. Our community is diverse, with many of our mothers coming from Black, Hispanic, Pacific Islander and other non-white backgrounds. According to the United States Census Bureau, approximately 43.4% of Long Beach's population identifies as Hispanic or Latino, 11.9% as Black or African American and 12.8% as Asian. The city also has a significant Cambodian community, which is the second-largest outside of Cambodia. As a community hospital serving the greater Long Beach area, we prioritize training and awareness around unconscious bias among our patients and caregivers. We have the necessary tools to effectively record and analyze data. Statistics from the Center for Disease Control and Prevention indicate that the maternal mortality rate for non-Hispanic Black women is 49.5 deaths per 100,000 live births – significantly higher than for White (19), Hispanic (16.9) and Asian (13.2) women in 2022. These disparities highlight the urgent need for focused interventions and systemic changes in maternal healthcare. Several factors contribute to the higher maternal mortality in minority communities. Structural racism and implicit bias within the healthcare system can lead to inadequate prenatal care, delayed diagnosis and treatment of pregnancy-related complications, and disparities in access to maternal healthcare services. Furthermore, socioeconomic factors further exacerbate these disparities in maternal outcomes among minority women. Addressing the crisis requires removing systemic barriers to quality maternal healthcare. Miller Children's & Women's Hospital recognizes the ongoing work needed in minority health and has made it a priority. No one should be denied basic or standard healthcare due to their race or ethnicity. Therefore, we are committed to becoming the change, recognizing that much work lies ahead. At the Cherese Mari Laulhere BirthCare Center at Miller Children's & Women's, our healthcare providers and care teams undergo cultural competency training to better understand the unique needs and experiences of minority patients. Additionally, we have partnered with the California Maternal Quality Care Collaborative as one of five hospitals selected for their significant demographics of racial and ethnic minority populations. This partnership focuses on addressing birth inequities, educating staff, sharing data and creating a Hospital Action Guide to empower hospitals nationwide to engage in this vital work. Since focusing on these initiatives, we have seen an almost 10% increase in Black mothers reporting that they always feel like they are treated with courtesy and respect. These patient-reported measures enhance the relationship between the patients and care providers to ensure that patients' voices are heard and that their birth experience preferences are honored. Evidence indicates that these improvements will help close the disparity gap in birth outcomes for Black women and their newborns. Currently, Miller Children's & Women's is working to implement all recommendations from the Association of Women's Health, Obstetric and Neonatal Nurses' (AWHONN) respectful maternal care framework and evidence-based clinical practice guidelines. Our care teams, including our Respectful Maternal Care Champions, are here to enhance the overall experience of our Black and Brown patients, utilizing technology like Irth App, a unique Yelp-like platform for parents of color to leave and find reviews of OB/GYNs, birthing hospitals and pediatricians. By analyzing patient responses shared through this app, we can redefine our care based on patient experiences and make births safer, more respectful and equitable. Want to learn more? Visit
USA Today
an hour ago
- USA Today
My 5-year-old survived cancer – twice. Don't put politics before medical research.
My 5-year-old survived cancer – twice. Don't put politics before medical research. | Opinion When you're watching your child battle cancer, every advancement matters. We can't afford to let misinformation and polarized politics dictate the future of lifesaving research. Show Caption Hide Caption Cuts to health research could impact clinical studies and trials at the NIH The Trump administration wants to cut health spending in the coming year, and plans to cut the budget at the National Institutes of Health by $18 billion. Few issues in American politics have consistently united both parties like the fight against cancer. While funding levels and strategies may differ, Democrats and Republicans alike recognize that cancer doesn't discriminate – and neither should our commitment to defeat it. Under the Biden administration, the Cancer Moonshot was relaunched to accelerate progress toward a cure. More recently, President Donald Trump announced his 'Stargate' initiative, which aims to harness artificial intelligence in detecting and treating cancer, including through personalized mRNA vaccines. In the United States, cancer is the leading cause of death by disease for children after infancy. Across the political spectrum, there remains a shared hope: that no one should have to endure the pain of losing a loved one or fight this deadly disease. Yet today, that consensus is showing signs of strain. State legislatures across the country are advancing bills to ban or severely restrict the use of – and further research into – breakthrough technologies like mRNA, a technology that is driving promising advancements in cancer. What should be a story of American scientific innovation is being twisted into a political talking point. And it's putting lives at risk. Opinion: Biden's diagnosis shows two things. Cancer hits everyone and some forgot that. My daughter survived cancer twice. Politicians can't imagine what we went through. If the politicians pushing these bans spent even a few minutes inside a pediatric oncology unit, maybe they'd understand. They'd see floors filled with sick children on small bicycles, pulling IV poles behind them. Children in hospital beds, brave beyond measure. And parents clinging to hope. I've seen it firsthand. I'm a mother whose 5-year-old daughter has survived cancer – twice. My daughter Charlie is one of a small percentage of pediatric cancer patients whose tumors don't show up on standard blood tests. Her cancer went undetected for more than a year. By the time doctors found it, it had already spread to her liver. She was just 3 years old and had Stage 4 cancer. Once Charlie's cancer was detected, we rushed into treatment: high-dose chemotherapy, stem cell transplants and multiple surgeries. After months of treatment, we got the news every parent prays for: Charlie was cancer-free. But just a few months later, scans revealed a relapse. Two small nodules were found on her lung. Her baby brother was only two months old when we learned her cancer had returned. Relapse treatment was grueling. Charlie lost weight and muscle mass. She needed a feeding tube to stay nourished, hydrated and medicated. But through it all, she never lost her smile. Her strength became ours. And while we juggled caring for a newborn and two other children, we held onto hope, because science gave us a reason to. Thanks to expert care at Seattle Children's and research-backed protocols, she's once again cancer-free. She started preschool this year. She's coloring, laughing and chasing her siblings again. Public funding for research saved my daughter's life Every option we had was made possible by decades of public investment in research. Families who came before us joined clinical trials. Lawmakers chose to fund pediatric science and cancer research. That is the same kind of work mRNA research builds on today. Researchers are developing an mRNA-based diagnostic test that could catch cancers like hers earlier, when they're more treatable. The test uses mRNA from her original tumor to detect any circulating cancer cells through a simple blood draw. Catching a relapse early could be lifesaving. We first learned about this test in 2023, and knowing it's almost within reach brings us, and families like ours, so much hope. Beyond mRNA-based diagnostic tests, mRNA has also shown early promise as a therapy for cancer patients, enabling personalized treatment that could more effectively target one's tumor. That kind of innovation is exactly what's under threat right now. The role of mRNA technology in oncology has been studied for decades, and yet some lawmakers want to roll this progress back, arguing it is untested and unsafe. This technology, along with many innovations that come from federally supported medical research, is a critical source of hope for families around the world. I'm a doctor. So is my mother. When she got cancer, I realized how little that mattered. | Opinion When you're watching your child battle cancer, every advancement matters. I know firsthand how critical it is to catch cancer early and have access to every possible treatment option. When politicians politicize science – when they ban or restrict it based on misinformation and politics – they aren't protecting families like mine. They're limiting our options. They're slowing down the breakthroughs that could save lives. We can't afford to let misinformation and polarized politics dictate the future of lifesaving research. Thanks to innovation in medical research, Charlie is thriving today, but far too many kids are still fighting. Let's ensure science continues to move forward for all of our children. Emily Stenson is a childhood cancer advocate and the mother of 5-year-old two-time cancer survivor Charlie Stenson. She lives in Seattle.
Boston Globe
11 hours ago
- Boston Globe
Palestinians say Israeli fire kills 12 near aid sites
Advertisement Eleven of the latest bodies were brought to Nasser Hospital in the southern city of Khan Younis. Palestinian witnesses said Israeli forces fired on some at a roundabout around a kilometer (half-mile) from a site run by the Gaza Humanitarian Foundation, or GHF, in nearby Rafah. Israel's military said it fired warning shots at approaching 'suspects' who ignored warnings to turn away. It said the shooting happened in an area that is considered an active combat zone at night. Al-Awda Hospital said it received the body of a man and 29 people who were wounded near another GHF aid distribution point in central Gaza. The military said it fired warning shots in the area at around 6:40 a.m., but didn't see any casualties. Advertisement A GHF official said there was no violence in or around its distribution sites, all three of which delivered aid on Sunday. The group closed them temporarily last week to discuss safety measures with Israel's military and has warned people to stay on designated access routes. The official spoke on condition of anonymity in line with regulations. The new aid hubs are set up inside Israeli military zones where independent media have no access. The GHF also said it was piloting direct delivery to a community north of Rafah. Witnesses said the first shootings in southern Gaza took place at around 6 a.m., when they were told the site would open. Many headed toward it early, seeking desperately needed food before crowds arrived. Gaza's roughly 2 million Palestinians are almost completely reliant on international aid because nearly all food production capabilities have been destroyed. Adham Dahman, who was at Nasser Hospital with a bandage on his chin, said a tank fired toward them. 'We didn't know how to escape,' he said. 'This is [a] trap for us, not aid.' Zahed Ben Hassan said someone next to him was shot in the head. 'They said it was a safe area from 6 a.m. until 6 p.m. ... So why did they start shooting at us?' he said. 'There was light out, and they have their cameras and can clearly see us.' The military announced on Friday that the sites would be open during those hours, and the areas would be a closed military zone the rest of the time. Children cried over their father's body at the hospital. 'I can't see you like this, Dad!' one girl said. Advertisement The new aid hubs are run by GHF, a new group of mainly American contractors. Israel wants it to replace a system coordinated by the United Nations and international aid groups. Israel and the United States accuse the Hamas militant group of stealing aid. The UN denies there is systematic diversion. The UN says the new system is unable to meet mounting needs, allows Israel to use aid as a weapon by determining who can receive it and forces people to relocate to where aid sites are positioned. The UN system has struggled to deliver aid, even after Israel eased its blockade of Gaza last month. UN officials say their efforts are hindered by Israeli military restrictions, the breakdown of law and order and widespread looting. Experts warned earlier this year that Gaza was at critical risk of famine, if Israel didn't lift its blockade and halt its military campaign. Both were renewed in March. Israeli officials have said the offensive will continue until all hostages are returned and Hamas is defeated or disarmed and sent into exile. On Sunday, Israel's military invited journalists into Khan Younis to show a tunnel under the European Hospital, saying they found the body of Mohammed Sinwar, the head of Hamas' armed wing, there after he was killed last month. Israel has barred international journalists from entering Gaza independently since the war began. '(Israeli forces) would prefer not to hit or target hospitals,' army spokesperson Brig. Gen. Effie Defrin said. Sinwar's body was found in a room under the hospital's emergency room, Defrin said. Hamas has said it will only release the remaining hostages in return for Palestinian prisoners, a lasting ceasefire and an Israeli withdrawal from Gaza. Talks mediated by the U.S., Egypt, and Qatar have been deadlocked for months. Advertisement Hamas started the war with its attack on southern Israel on Oct. 7, 2023, when Palestinian militants killed around 1,200 people, mostly civilians, and took another 251 hostage. They still hold 55 hostages, fewer than half of them alive, after most of the rest were released in ceasefire agreements or other deals. Israel's military campaign has killed more than 54,800 Palestinians, according to Gaza's Health Ministry. It says women and children make up most of the dead, but doesn't say how many civilians or combatants were killed. Israel says it has killed more than 20,000 militants, without providing evidence. The war has destroyed vast areas of Gaza and displaced around 90 percent of its population.
